March 05, 2022
Video
Kevin Kalinsky, MD, MS, discussed selective estrogen receptor downregulators being explored for the treatment of breast cancer clinical trials.
February 24, 2022
Video
Guidance on how to treat a 67-year-old patient with ER-positive/PR-positive breast cancer, and additional therapies in the pipeline that have the potential to improve treatment.
February 24, 2022
Video
An overview of CDK4/6 inhibitors available for patients with advanced or metastatic HR-positive breast cancer, and recommendations for managing common adverse events associated with therapy.
February 24, 2022
Video
The rationale for treating patients with early-stage HR-positive breast cancer with abemaciclib and endocrine therapy.
February 24, 2022
Video
Criteria used by breast oncologists to risk stratify patients who present with HR-positive breast cancer.
February 24, 2022
Video
Kevin Kalinsky, MD, MS, presents a case of ER-positive/PR-positive breast cancer and highlights the prevalence of cases such as this in the United States.